These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6820378)
1. [Significance of chemo-endocrine therapy in advanced breast cancer--a combined administration of tamoxifen, tegafur, and cyclophosphamide]. Wada T; Koyama H; Nishizawa Y; Iwanaga T; Terasawa T Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2093-100. PubMed ID: 6820378 [No Abstract] [Full Text] [Related]
2. [Chemo-endocrine therapy for advanced breast cancer--a combined treatment with tamoxifen and FT 207-- (author's transl)]. Wada T; Koyama H; Nishizawa Y; Takahashi Y; Fukuda I; Iwanaga T; Terasawa T Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):51-5. PubMed ID: 6790640 [No Abstract] [Full Text] [Related]
3. [ACFT therapy using adriamycin, cyclophosphamide, tegafur and tamoxifen against progressive breast cancer]. Watanabe Y; Tamura M; Meguro F Gan To Kagaku Ryoho; 1988 May; 15(5):1711-4. PubMed ID: 3130805 [TBL] [Abstract][Full Text] [Related]
4. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]. Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231 [TBL] [Abstract][Full Text] [Related]
5. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)]. Heuson JC; Paridaens R Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007 [No Abstract] [Full Text] [Related]
6. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer]. Yamaguchi S; Fukuda M; Ota T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy in curable breast cancer]. Seradour B; Thomas M J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124 [No Abstract] [Full Text] [Related]
8. [Chemotherapy of advanced breast cancer--actual results ]. Matthes ML; Lenk H; Gürtler R; Tanneberger S Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538 [TBL] [Abstract][Full Text] [Related]
9. [ACF combination consisting of adriamycin, cyclophosphamide and oral futraful for recurrent advanced breast cancer (author's transl)]. Murosaki S; Inagaki J; Horikoshi N; Esaki K; Inoue K; Nagura E; Ueoka H; Takano Y; Kobayashi T; Okabe K; Ogawa M Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):8-14. PubMed ID: 6790641 [No Abstract] [Full Text] [Related]
10. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma. Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules]. Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849 [No Abstract] [Full Text] [Related]
12. Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: a sequential trial. Wada T; Koyama H; Terasawa T Breast Cancer Res Treat; 1981; 1(1):53-8. PubMed ID: 6816315 [TBL] [Abstract][Full Text] [Related]
13. [Randomized comparative study of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) and UFT-tamoxifen regimens as adjuvant chemotherapy after surgery for breast cancer: Tochigi Prefectural Study Group for Post-Breast Cancer Adjuvant Chemotherapy]. Tamura H; Kojima M; Kobayashi H; Ando J; Oka S; Fujisaki M; Wada N; Imoto S; Ikeda T Gan To Kagaku Ryoho; 2000 Jul; 27(7):993-1002. PubMed ID: 10925684 [TBL] [Abstract][Full Text] [Related]
14. [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia]. Terazaki Y; Nagamatsu H; Ono H; Iwakuma N; Shirouzu K Gan To Kagaku Ryoho; 2005 May; 32(5):675-7. PubMed ID: 15918571 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study of preoperative chemotherapy of primary breast cancer. 1. Efficacy of a combined use of CPA (endoxan) and FT-207 (or 5-FU dry syrup)]. Komuro K; Hara Y; Fujii Y; Yamazaki M; Amano R; Hashiguchi F; Sakamoto R; Nakamura R; Shimada A; Kurata T; Ando H; Nakamura K Gan To Kagaku Ryoho; 1982 Dec; 9(12):2180-5. PubMed ID: 6820892 [TBL] [Abstract][Full Text] [Related]
16. [A case report of advanced breast cancer effectively treated by chemo-endocrine therapy with diethylstilbestrol diphosphate and cyclophosphamide]. Hareyama M; Saito A; Oouchi A; Morita K Gan To Kagaku Ryoho; 1989 Jul; 16(7):2453-6. PubMed ID: 2751322 [TBL] [Abstract][Full Text] [Related]
17. [Effect of CAF'-endocrine therapy on advanced and recurrent breast cancer]. Une Y; Sato Y; Kagaya H; Miyata S; Matsuoka S; Uchino J; Yakura Y Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2778-81. PubMed ID: 6548892 [TBL] [Abstract][Full Text] [Related]
18. [Alternative treatment with carmustine, vindesine and tamoxifen in previously cytostaticly (VAC, FMC) treated patients with metastatic breast cancer]. Massner B; Voss I; Queisser W; Drings P; Fritze D; Westerhausen M Onkologie; 1982 Aug; 5 Suppl():46-51. PubMed ID: 6752791 [TBL] [Abstract][Full Text] [Related]
19. [Present status of endocrine therapy of breast cancer: a surgeon's view]. Nomura Y Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405 [TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group. Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282 [No Abstract] [Full Text] [Related] [Next] [New Search]